ArticleJournal of neurology2026
Intellectual disability and structural defects of the CaV2.1 channel in episodic ataxia type 2: correlation using an AI prediction model.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Episodic Ataxia Type 2 Presenting with Fluctuating Weakness in a Child with a De Novo CACNA1A Variant.Children (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundEpisodic ataxia type 2 (EA2) results from pathogenic variants in CACNA1A that encodes the CaV2.1 P/Q-type calcium channel. The molecular basis of cognitive impairments requires further elucidation in EA2.
objectiveTo correlate AI-predicted structural alterations of the CaV2.1 channel with intellectual function observed in patients with EA2.
methodsUsing AlphaFold3, we modeled the wild-type and variant CACNA1A proteins. Structural similarity between the wild-type and variant proteins was quantified using the Template Modeling (TM) score. To assess degree of truncation, the relative amino acid length ratio (AA%) was also calculated. These protein-level metrics were then compared with the standardized intellectual indices in 13 patients with EA2.
resultsThe TM scores ranged from 0.624 to 0.838, and showed a strong correlation with most intellectual indices, including the full-scale IQ (FSIQ, r = 0.722, p = 0.005), verbal comprehension index (VCI, r = 0.834, p < 0.001), perceptual reasoning index (PRI, r = 0.624, p = 0.023), and working memory index (WMI, r = 0.700, p = 0.008). The AA% ranged from 50.6% to 100%, and also showed a correlation with VCI (r = 0.566, p = 0.044) and WMI (r = 0.649, p = 0.016), but less consistently when compared to the TM score.
conclusionsStructural preservation of CaV2.1 correlates more strongly with intellectual function in patients with EA2 than protein length, which suggests that structural disruption of the CaV2.1 channel may contribute to cognitive impairments in EA2. AI-based protein modeling is a valuable tool for linking genotype to phenotype, particularly in channelopathies with diverse clinical presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.